Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India

India approved COVID-19 vaccine called Covaxin, developed by the Indian Council of Medical Research and Bharat Biotech Ltd. The primary objective of the study was to estimate the effectiveness of Covaxin in preventing breakthrough SARS-CoV-2 infection in healthcare workers (HCWs). A test-negative ma...

Full description

Bibliographic Details
Published in:Human Vaccines & Immunotherapeutics
Main Authors: Priyamadhaba Behera, Arvind Kumar Singh, Sonu Hangma Subba, Arjun Mc, Dinesh Prasad Sahu, Pradnya Dilip Chandanshive, Somen Kumar Pradhan, Swayam Pragyan Parida, Abhisek Mishra, Binod Kumar Patro, Gitanjali Batmanabane
Format: Article
Language:English
Published: Taylor & Francis Group 2022-01-01
Subjects:
covid-19
vaccine
effectiveness
covaxin
india
Online Access:http://dx.doi.org/10.1080/21645515.2022.2034456

Internet

http://dx.doi.org/10.1080/21645515.2022.2034456

Similar Items